Reference Number
RF178969
Description
Lenvatinib is a multi-target drug that is different from other tyrosine kinase inhibitors (TKIs). It is currently approved for liver cancer, thyroid cancer and renal cancer. It is a new targeted drug for the treatment of liver cancer. As a multi-target drug, in addition to its approved indications for thyroid cancer and renal cancer, it has also been approved for the treatment of liver cancer. You can know lenvatinib price in Philippines by contacting us.
Lenvatinib is a multi-target drug that is different from other tyrosine kinase inhibitors (TKIs). It is currently approved for liver cancer, thyroid cancer and renal cancer. It is a new targeted drug for the treatment of liver cancer. As a multi-target drug, in addition to its approved indications for thyroid cancer and renal cancer, it has also been approved for the treatment of liver cancer. You can know lenvatinib price in Philippines by contacting us.
Lenvatinib is a multi-target drug that is different from other tyrosine kinase inhibitors (TKIs). It is currently approved for liver cancer, thyroid cancer and renal cancer. It is a new targeted drug for the treatment of liver cancer. As a multi-target drug, in addition to its approved indications for thyroid cancer and renal cancer, it has also been approved for the treatment of liver cancer. You can know lenvatinib price in Philippines by contacting us.
website
Country
India
State/Region/Province
Haryana
-
Save as PDF
-
- Current rating: 0
- Total votes: 0
-
View QR Code
- 122 Views